nodes	percent_of_prediction	percent_of_DWPC	metapath
Voriconazole—CYP3A7—Docetaxel—head and neck cancer	0.115	0.247	CbGbCtD
Voriconazole—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.115	0.247	CbGbCtD
Voriconazole—CYP3A5—Docetaxel—head and neck cancer	0.0861	0.185	CbGbCtD
Voriconazole—CYP2C9—Fluorouracil—head and neck cancer	0.0756	0.162	CbGbCtD
Voriconazole—CYP3A4—Vinblastine—head and neck cancer	0.0407	0.0875	CbGbCtD
Voriconazole—CYP3A4—Docetaxel—head and neck cancer	0.0336	0.0721	CbGbCtD
Voriconazole—FMO1—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00417	0.0594	CbGpPWpGaD
Voriconazole—FMO3—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00298	0.0425	CbGpPWpGaD
Voriconazole—FMO1—Biological oxidations—NAT2—head and neck cancer	0.00165	0.0236	CbGpPWpGaD
Voriconazole—FMO1—Metapathway biotransformation—NAT2—head and neck cancer	0.00163	0.0233	CbGpPWpGaD
Voriconazole—Amnesia—Fluorouracil—head and neck cancer	0.00156	0.00336	CcSEcCtD
Voriconazole—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00154	0.00332	CcSEcCtD
Voriconazole—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00154	0.00332	CcSEcCtD
Voriconazole—Hypoaesthesia—Vinblastine—head and neck cancer	0.00154	0.00331	CcSEcCtD
Voriconazole—Pharyngitis—Vinblastine—head and neck cancer	0.00153	0.00331	CcSEcCtD
Voriconazole—Hearing impaired—Docetaxel—head and neck cancer	0.00153	0.0033	CcSEcCtD
Voriconazole—Stomatitis—Hydroxyurea—head and neck cancer	0.00153	0.0033	CcSEcCtD
Voriconazole—Bone pain—Docetaxel—head and neck cancer	0.00152	0.00328	CcSEcCtD
Voriconazole—Inflammation—Docetaxel—head and neck cancer	0.0015	0.00324	CcSEcCtD
Voriconazole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00149	0.0032	CcSEcCtD
Voriconazole—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00147	0.00316	CcSEcCtD
Voriconazole—Hepatocellular injury—Docetaxel—head and neck cancer	0.00146	0.00314	CcSEcCtD
Voriconazole—Pulmonary embolism—Docetaxel—head and neck cancer	0.00146	0.00314	CcSEcCtD
Voriconazole—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00146	0.00314	CcSEcCtD
Voriconazole—FMO1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00146	0.0208	CbGpPWpGaD
Voriconazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00146	0.0208	CbGpPWpGaD
Voriconazole—Injection site reaction—Docetaxel—head and neck cancer	0.00145	0.00312	CcSEcCtD
Voriconazole—Influenza like illness—Docetaxel—head and neck cancer	0.00142	0.00305	CcSEcCtD
Voriconazole—Hallucination—Hydroxyurea—head and neck cancer	0.0014	0.00302	CcSEcCtD
Voriconazole—Cardiac arrest—Fluorouracil—head and neck cancer	0.0014	0.00301	CcSEcCtD
Voriconazole—Ataxia—Fluorouracil—head and neck cancer	0.00138	0.00297	CcSEcCtD
Voriconazole—Neuropathy—Docetaxel—head and neck cancer	0.00137	0.00295	CcSEcCtD
Voriconazole—Alopecia—Vinblastine—head and neck cancer	0.00137	0.00294	CcSEcCtD
Voriconazole—Dry skin—Fluorouracil—head and neck cancer	0.00135	0.0029	CcSEcCtD
Voriconazole—Oesophagitis—Docetaxel—head and neck cancer	0.00133	0.00287	CcSEcCtD
Voriconazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00133	0.019	CbGpPWpGaD
Voriconazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00133	0.0189	CbGpPWpGaD
Voriconazole—Pulmonary oedema—Docetaxel—head and neck cancer	0.0013	0.0028	CcSEcCtD
Voriconazole—Muscular weakness—Fluorouracil—head and neck cancer	0.00129	0.00279	CcSEcCtD
Voriconazole—Angiopathy—Hydroxyurea—head and neck cancer	0.00128	0.00276	CcSEcCtD
Voriconazole—Dysphagia—Fluorouracil—head and neck cancer	0.00127	0.00273	CcSEcCtD
Voriconazole—Sepsis—Docetaxel—head and neck cancer	0.00127	0.00273	CcSEcCtD
Voriconazole—Chills—Hydroxyurea—head and neck cancer	0.00127	0.00273	CcSEcCtD
Voriconazole—Eosinophilia—Fluorouracil—head and neck cancer	0.00126	0.0027	CcSEcCtD
Voriconazole—CYP3A7—Xenobiotics—CYP1A1—head and neck cancer	0.00125	0.0179	CbGpPWpGaD
Voriconazole—Ill-defined disorder—Vinblastine—head and neck cancer	0.00125	0.00269	CcSEcCtD
Voriconazole—Alopecia—Hydroxyurea—head and neck cancer	0.00125	0.00268	CcSEcCtD
Voriconazole—Anaemia—Vinblastine—head and neck cancer	0.00124	0.00268	CcSEcCtD
Voriconazole—Phlebitis—Docetaxel—head and neck cancer	0.00123	0.00265	CcSEcCtD
Voriconazole—Erythema—Hydroxyurea—head and neck cancer	0.00123	0.00264	CcSEcCtD
Voriconazole—Thrombophlebitis—Docetaxel—head and neck cancer	0.00122	0.00264	CcSEcCtD
Voriconazole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00122	0.00262	CcSEcCtD
Voriconazole—Malaise—Vinblastine—head and neck cancer	0.00121	0.00261	CcSEcCtD
Voriconazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00121	0.0173	CbGpPWpGaD
Voriconazole—Vertigo—Vinblastine—head and neck cancer	0.00121	0.00261	CcSEcCtD
Voriconazole—Leukopenia—Vinblastine—head and neck cancer	0.00121	0.0026	CcSEcCtD
Voriconazole—Pancytopenia—Fluorouracil—head and neck cancer	0.0012	0.00259	CcSEcCtD
Voriconazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00118	0.0169	CbGpPWpGaD
Voriconazole—Deafness—Docetaxel—head and neck cancer	0.00118	0.00255	CcSEcCtD
Voriconazole—FMO3—Biological oxidations—NAT2—head and neck cancer	0.00118	0.0169	CbGpPWpGaD
Voriconazole—Hepatic failure—Docetaxel—head and neck cancer	0.00118	0.00254	CcSEcCtD
Voriconazole—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00117	0.00252	CcSEcCtD
Voriconazole—FMO3—Metapathway biotransformation—NAT2—head and neck cancer	0.00117	0.0166	CbGpPWpGaD
Voriconazole—Convulsion—Vinblastine—head and neck cancer	0.00117	0.00251	CcSEcCtD
Voriconazole—Hypertension—Vinblastine—head and neck cancer	0.00116	0.0025	CcSEcCtD
Voriconazole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00116	0.00249	CcSEcCtD
Voriconazole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00114	0.00245	CcSEcCtD
Voriconazole—Pneumonia—Fluorouracil—head and neck cancer	0.00114	0.00245	CcSEcCtD
Voriconazole—Anaemia—Hydroxyurea—head and neck cancer	0.00113	0.00244	CcSEcCtD
Voriconazole—Discomfort—Vinblastine—head and neck cancer	0.00113	0.00244	CcSEcCtD
Voriconazole—Infestation NOS—Fluorouracil—head and neck cancer	0.00113	0.00244	CcSEcCtD
Voriconazole—Infestation—Fluorouracil—head and neck cancer	0.00113	0.00244	CcSEcCtD
Voriconazole—Atrial fibrillation—Docetaxel—head and neck cancer	0.00112	0.00241	CcSEcCtD
Voriconazole—Visual disturbance—Docetaxel—head and neck cancer	0.00112	0.00241	CcSEcCtD
Voriconazole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00111	0.0024	CcSEcCtD
Voriconazole—Renal impairment—Docetaxel—head and neck cancer	0.00111	0.0024	CcSEcCtD
Voriconazole—Myocardial infarction—Fluorouracil—head and neck cancer	0.00111	0.00239	CcSEcCtD
Voriconazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00111	0.00239	CcSEcCtD
Voriconazole—Malaise—Hydroxyurea—head and neck cancer	0.00111	0.00238	CcSEcCtD
Voriconazole—Stomatitis—Fluorouracil—head and neck cancer	0.0011	0.00237	CcSEcCtD
Voriconazole—Urinary tract infection—Fluorouracil—head and neck cancer	0.0011	0.00237	CcSEcCtD
Voriconazole—Conjunctivitis—Fluorouracil—head and neck cancer	0.0011	0.00237	CcSEcCtD
Voriconazole—Leukopenia—Hydroxyurea—head and neck cancer	0.0011	0.00237	CcSEcCtD
Voriconazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.00108	0.00232	CcSEcCtD
Voriconazole—Epistaxis—Fluorouracil—head and neck cancer	0.00107	0.0023	CcSEcCtD
Voriconazole—Convulsion—Hydroxyurea—head and neck cancer	0.00106	0.00229	CcSEcCtD
Voriconazole—Hyponatraemia—Docetaxel—head and neck cancer	0.00106	0.00229	CcSEcCtD
Voriconazole—Sinusitis—Fluorouracil—head and neck cancer	0.00106	0.00229	CcSEcCtD
Voriconazole—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00106	0.00228	CcSEcCtD
Voriconazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.00106	0.00227	CcSEcCtD
Voriconazole—Anorexia—Vinblastine—head and neck cancer	0.00105	0.00226	CcSEcCtD
Voriconazole—FMO3—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00104	0.0149	CbGpPWpGaD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00104	0.00224	CcSEcCtD
Voriconazole—Discomfort—Hydroxyurea—head and neck cancer	0.00103	0.00222	CcSEcCtD
Voriconazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00103	0.0147	CbGpPWpGaD
Voriconazole—Rhinitis—Fluorouracil—head and neck cancer	0.00102	0.00219	CcSEcCtD
Voriconazole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00101	0.00218	CcSEcCtD
Voriconazole—Pharyngitis—Fluorouracil—head and neck cancer	0.00101	0.00217	CcSEcCtD
Voriconazole—Oedema—Hydroxyurea—head and neck cancer	0.001	0.00216	CcSEcCtD
Voriconazole—Ataxia—Docetaxel—head and neck cancer	0.000996	0.00215	CcSEcCtD
Voriconazole—Infection—Hydroxyurea—head and neck cancer	0.000996	0.00214	CcSEcCtD
Voriconazole—Paraesthesia—Vinblastine—head and neck cancer	0.000987	0.00213	CcSEcCtD
Voriconazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000983	0.00212	CcSEcCtD
Voriconazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000981	0.00211	CcSEcCtD
Voriconazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.000978	0.00211	CcSEcCtD
Voriconazole—Skin disorder—Hydroxyurea—head and neck cancer	0.000973	0.0021	CcSEcCtD
Voriconazole—Dry skin—Docetaxel—head and neck cancer	0.000971	0.00209	CcSEcCtD
Voriconazole—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000967	0.00208	CcSEcCtD
Voriconazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—head and neck cancer	0.000961	0.0137	CbGpPWpGaD
Voriconazole—Anorexia—Hydroxyurea—head and neck cancer	0.000955	0.00206	CcSEcCtD
Voriconazole—Decreased appetite—Vinblastine—head and neck cancer	0.000955	0.00206	CcSEcCtD
Voriconazole—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000954	0.00205	CcSEcCtD
Voriconazole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000954	0.00205	CcSEcCtD
Voriconazole—Pain—Vinblastine—head and neck cancer	0.00094	0.00202	CcSEcCtD
Voriconazole—Constipation—Vinblastine—head and neck cancer	0.00094	0.00202	CcSEcCtD
Voriconazole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000934	0.00201	CcSEcCtD
Voriconazole—CYP2B6—Xenobiotics—CYP1A1—head and neck cancer	0.000927	0.0132	CbGpPWpGaD
Voriconazole—Dysphagia—Docetaxel—head and neck cancer	0.000915	0.00197	CcSEcCtD
Voriconazole—Arrhythmia—Fluorouracil—head and neck cancer	0.000907	0.00195	CcSEcCtD
Voriconazole—CYP3A5—Xenobiotics—CYP1A1—head and neck cancer	0.000906	0.0129	CbGpPWpGaD
Voriconazole—Feeling abnormal—Vinblastine—head and neck cancer	0.000905	0.00195	CcSEcCtD
Voriconazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000899	0.00194	CcSEcCtD
Voriconazole—Alopecia—Fluorouracil—head and neck cancer	0.000897	0.00193	CcSEcCtD
Voriconazole—Dyspnoea—Hydroxyurea—head and neck cancer	0.000893	0.00192	CcSEcCtD
Voriconazole—Somnolence—Hydroxyurea—head and neck cancer	0.000891	0.00192	CcSEcCtD
Voriconazole—Erythema—Fluorouracil—head and neck cancer	0.000884	0.0019	CcSEcCtD
Voriconazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.000882	0.0019	CcSEcCtD
Voriconazole—CYP3A5—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000872	0.0124	CbGpPWpGaD
Voriconazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.000871	0.00188	CcSEcCtD
Voriconazole—Pancytopenia—Docetaxel—head and neck cancer	0.000869	0.00187	CcSEcCtD
Voriconazole—Abdominal pain—Vinblastine—head and neck cancer	0.000869	0.00187	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000865	0.00186	CcSEcCtD
Voriconazole—Constipation—Hydroxyurea—head and neck cancer	0.000857	0.00185	CcSEcCtD
Voriconazole—Pain—Hydroxyurea—head and neck cancer	0.000857	0.00185	CcSEcCtD
Voriconazole—Vision blurred—Fluorouracil—head and neck cancer	0.000833	0.00179	CcSEcCtD
Voriconazole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000826	0.00178	CcSEcCtD
Voriconazole—Pneumonia—Docetaxel—head and neck cancer	0.000821	0.00177	CcSEcCtD
Voriconazole—FMO1—Biological oxidations—GSTM1—head and neck cancer	0.000817	0.0117	CbGpPWpGaD
Voriconazole—Anaemia—Fluorouracil—head and neck cancer	0.000817	0.00176	CcSEcCtD
Voriconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000816	0.0116	CbGpPWpGaD
Voriconazole—Infestation NOS—Docetaxel—head and neck cancer	0.000816	0.00176	CcSEcCtD
Voriconazole—Infestation—Docetaxel—head and neck cancer	0.000816	0.00176	CcSEcCtD
Voriconazole—Hypersensitivity—Vinblastine—head and neck cancer	0.00081	0.00174	CcSEcCtD
Voriconazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000809	0.00174	CcSEcCtD
Voriconazole—FMO1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000806	0.0115	CbGpPWpGaD
Voriconazole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000805	0.00173	CcSEcCtD
Voriconazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0008	0.00172	CcSEcCtD
Voriconazole—Myocardial infarction—Docetaxel—head and neck cancer	0.0008	0.00172	CcSEcCtD
Voriconazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000798	0.0114	CbGpPWpGaD
Voriconazole—Jaundice—Docetaxel—head and neck cancer	0.000796	0.00171	CcSEcCtD
Voriconazole—Stomatitis—Docetaxel—head and neck cancer	0.000796	0.00171	CcSEcCtD
Voriconazole—Conjunctivitis—Docetaxel—head and neck cancer	0.000793	0.00171	CcSEcCtD
Voriconazole—PTGS1—Overview of nanoparticle effects—BCL2—head and neck cancer	0.000793	0.0113	CbGpPWpGaD
Voriconazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000792	0.00171	CcSEcCtD
Voriconazole—Leukopenia—Fluorouracil—head and neck cancer	0.000791	0.0017	CcSEcCtD
Voriconazole—Asthenia—Vinblastine—head and neck cancer	0.000788	0.0017	CcSEcCtD
Voriconazole—FMO1—Biological oxidations—CYP1A1—head and neck cancer	0.000775	0.011	CbGpPWpGaD
Voriconazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000772	0.00166	CcSEcCtD
Voriconazole—Epistaxis—Docetaxel—head and neck cancer	0.00077	0.00166	CcSEcCtD
Voriconazole—Convulsion—Fluorouracil—head and neck cancer	0.000766	0.00165	CcSEcCtD
Voriconazole—FMO1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000764	0.0109	CbGpPWpGaD
Voriconazole—Agranulocytosis—Docetaxel—head and neck cancer	0.000762	0.00164	CcSEcCtD
Voriconazole—PTGS1—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.000753	0.0107	CbGpPWpGaD
Voriconazole—Myalgia—Fluorouracil—head and neck cancer	0.000752	0.00162	CcSEcCtD
Voriconazole—Chest pain—Fluorouracil—head and neck cancer	0.000752	0.00162	CcSEcCtD
Voriconazole—Diarrhoea—Vinblastine—head and neck cancer	0.000752	0.00162	CcSEcCtD
Voriconazole—Discomfort—Fluorouracil—head and neck cancer	0.000743	0.0016	CcSEcCtD
Voriconazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000738	0.00159	CcSEcCtD
Voriconazole—Rhinitis—Docetaxel—head and neck cancer	0.000735	0.00158	CcSEcCtD
Voriconazole—Hepatitis—Docetaxel—head and neck cancer	0.000733	0.00158	CcSEcCtD
Voriconazole—Hypoaesthesia—Docetaxel—head and neck cancer	0.000729	0.00157	CcSEcCtD
Voriconazole—Confusional state—Fluorouracil—head and neck cancer	0.000727	0.00157	CcSEcCtD
Voriconazole—Pharyngitis—Docetaxel—head and neck cancer	0.000727	0.00157	CcSEcCtD
Voriconazole—Dizziness—Vinblastine—head and neck cancer	0.000727	0.00156	CcSEcCtD
Voriconazole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000724	0.00156	CcSEcCtD
Voriconazole—Oedema peripheral—Docetaxel—head and neck cancer	0.000722	0.00155	CcSEcCtD
Voriconazole—Oedema—Fluorouracil—head and neck cancer	0.000721	0.00155	CcSEcCtD
Voriconazole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000721	0.00155	CcSEcCtD
Voriconazole—Connective tissue disorder—Docetaxel—head and neck cancer	0.00072	0.00155	CcSEcCtD
Voriconazole—Asthenia—Hydroxyurea—head and neck cancer	0.000719	0.00155	CcSEcCtD
Voriconazole—Urethral disorder—Docetaxel—head and neck cancer	0.000718	0.00155	CcSEcCtD
Voriconazole—Infection—Fluorouracil—head and neck cancer	0.000717	0.00154	CcSEcCtD
Voriconazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.000707	0.00152	CcSEcCtD
Voriconazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000706	0.00152	CcSEcCtD
Voriconazole—Visual impairment—Docetaxel—head and neck cancer	0.000706	0.00152	CcSEcCtD
Voriconazole—Tachycardia—Fluorouracil—head and neck cancer	0.000704	0.00152	CcSEcCtD
Voriconazole—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000701	0.00999	CbGpPWpGaD
Voriconazole—Vomiting—Vinblastine—head and neck cancer	0.000699	0.0015	CcSEcCtD
Voriconazole—Erythema multiforme—Docetaxel—head and neck cancer	0.000693	0.00149	CcSEcCtD
Voriconazole—Headache—Vinblastine—head and neck cancer	0.000688	0.00148	CcSEcCtD
Voriconazole—Anorexia—Fluorouracil—head and neck cancer	0.000688	0.00148	CcSEcCtD
Voriconazole—Diarrhoea—Hydroxyurea—head and neck cancer	0.000686	0.00148	CcSEcCtD
Voriconazole—Eye disorder—Docetaxel—head and neck cancer	0.000685	0.00147	CcSEcCtD
Voriconazole—FMO1—Metabolism—UROD—head and neck cancer	0.000682	0.00972	CbGpPWpGaD
Voriconazole—Flushing—Docetaxel—head and neck cancer	0.00068	0.00146	CcSEcCtD
Voriconazole—Cardiac disorder—Docetaxel—head and neck cancer	0.00068	0.00146	CcSEcCtD
Voriconazole—Hypotension—Fluorouracil—head and neck cancer	0.000674	0.00145	CcSEcCtD
Voriconazole—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000674	0.00961	CbGpPWpGaD
Voriconazole—Angiopathy—Docetaxel—head and neck cancer	0.000665	0.00143	CcSEcCtD
Voriconazole—Dizziness—Hydroxyurea—head and neck cancer	0.000663	0.00143	CcSEcCtD
Voriconazole—Immune system disorder—Docetaxel—head and neck cancer	0.000662	0.00143	CcSEcCtD
Voriconazole—Mediastinal disorder—Docetaxel—head and neck cancer	0.00066	0.00142	CcSEcCtD
Voriconazole—Chills—Docetaxel—head and neck cancer	0.000657	0.00142	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000657	0.00142	CcSEcCtD
Voriconazole—Arrhythmia—Docetaxel—head and neck cancer	0.000655	0.00141	CcSEcCtD
Voriconazole—Nausea—Vinblastine—head and neck cancer	0.000653	0.00141	CcSEcCtD
Voriconazole—Insomnia—Fluorouracil—head and neck cancer	0.000652	0.00141	CcSEcCtD
Voriconazole—Paraesthesia—Fluorouracil—head and neck cancer	0.000648	0.00139	CcSEcCtD
Voriconazole—Alopecia—Docetaxel—head and neck cancer	0.000648	0.00139	CcSEcCtD
Voriconazole—Dyspnoea—Fluorouracil—head and neck cancer	0.000643	0.00138	CcSEcCtD
Voriconazole—Mental disorder—Docetaxel—head and neck cancer	0.000642	0.00138	CcSEcCtD
Voriconazole—Somnolence—Fluorouracil—head and neck cancer	0.000641	0.00138	CcSEcCtD
Voriconazole—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000639	0.00911	CbGpPWpGaD
Voriconazole—Malnutrition—Docetaxel—head and neck cancer	0.000638	0.00137	CcSEcCtD
Voriconazole—Erythema—Docetaxel—head and neck cancer	0.000638	0.00137	CcSEcCtD
Voriconazole—Vomiting—Hydroxyurea—head and neck cancer	0.000637	0.00137	CcSEcCtD
Voriconazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000635	0.00137	CcSEcCtD
Voriconazole—Rash—Hydroxyurea—head and neck cancer	0.000632	0.00136	CcSEcCtD
Voriconazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000631	0.00136	CcSEcCtD
Voriconazole—Headache—Hydroxyurea—head and neck cancer	0.000628	0.00135	CcSEcCtD
Voriconazole—Decreased appetite—Fluorouracil—head and neck cancer	0.000627	0.00135	CcSEcCtD
Voriconazole—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.000625	0.0089	CbGpPWpGaD
Voriconazole—Dysgeusia—Docetaxel—head and neck cancer	0.000625	0.00135	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000623	0.00134	CcSEcCtD
Voriconazole—Back pain—Docetaxel—head and neck cancer	0.000617	0.00133	CcSEcCtD
Voriconazole—Pain—Fluorouracil—head and neck cancer	0.000617	0.00133	CcSEcCtD
Voriconazole—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000614	0.00876	CbGpPWpGaD
Voriconazole—Muscle spasms—Docetaxel—head and neck cancer	0.000613	0.00132	CcSEcCtD
Voriconazole—Nausea—Hydroxyurea—head and neck cancer	0.000595	0.00128	CcSEcCtD
Voriconazole—Feeling abnormal—Fluorouracil—head and neck cancer	0.000594	0.00128	CcSEcCtD
Voriconazole—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00059	0.00841	CbGpPWpGaD
Voriconazole—Anaemia—Docetaxel—head and neck cancer	0.00059	0.00127	CcSEcCtD
Voriconazole—FMO3—Biological oxidations—GSTM1—head and neck cancer	0.000584	0.00833	CbGpPWpGaD
Voriconazole—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000584	0.00832	CbGpPWpGaD
Voriconazole—FMO3—Metapathway biotransformation—GSTM1—head and neck cancer	0.000576	0.00821	CbGpPWpGaD
Voriconazole—Urticaria—Fluorouracil—head and neck cancer	0.000573	0.00123	CcSEcCtD
Voriconazole—Syncope—Docetaxel—head and neck cancer	0.000572	0.00123	CcSEcCtD
Voriconazole—Leukopenia—Docetaxel—head and neck cancer	0.000571	0.00123	CcSEcCtD
Voriconazole—Body temperature increased—Fluorouracil—head and neck cancer	0.00057	0.00123	CcSEcCtD
Voriconazole—Palpitations—Docetaxel—head and neck cancer	0.000564	0.00121	CcSEcCtD
Voriconazole—Loss of consciousness—Docetaxel—head and neck cancer	0.000561	0.00121	CcSEcCtD
Voriconazole—Cough—Docetaxel—head and neck cancer	0.000557	0.0012	CcSEcCtD
Voriconazole—FMO3—Biological oxidations—CYP1A1—head and neck cancer	0.000554	0.0079	CbGpPWpGaD
Voriconazole—Convulsion—Docetaxel—head and neck cancer	0.000553	0.00119	CcSEcCtD
Voriconazole—Hypertension—Docetaxel—head and neck cancer	0.000551	0.00119	CcSEcCtD
Voriconazole—FMO3—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000546	0.00779	CbGpPWpGaD
Voriconazole—Chest pain—Docetaxel—head and neck cancer	0.000543	0.00117	CcSEcCtD
Voriconazole—Myalgia—Docetaxel—head and neck cancer	0.000543	0.00117	CcSEcCtD
Voriconazole—Arthralgia—Docetaxel—head and neck cancer	0.000543	0.00117	CcSEcCtD
Voriconazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000539	0.00116	CcSEcCtD
Voriconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000538	0.00767	CbGpPWpGaD
Voriconazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000531	0.00114	CcSEcCtD
Voriconazole—Dry mouth—Docetaxel—head and neck cancer	0.000531	0.00114	CcSEcCtD
Voriconazole—Confusional state—Docetaxel—head and neck cancer	0.000525	0.00113	CcSEcCtD
Voriconazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.000523	0.00745	CbGpPWpGaD
Voriconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000521	0.00742	CbGpPWpGaD
Voriconazole—Oedema—Docetaxel—head and neck cancer	0.000521	0.00112	CcSEcCtD
Voriconazole—Anaphylactic shock—Docetaxel—head and neck cancer	0.000521	0.00112	CcSEcCtD
Voriconazole—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000521	0.00742	CbGpPWpGaD
Voriconazole—Infection—Docetaxel—head and neck cancer	0.000517	0.00111	CcSEcCtD
Voriconazole—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000514	0.00732	CbGpPWpGaD
Voriconazole—Shock—Docetaxel—head and neck cancer	0.000512	0.0011	CcSEcCtD
Voriconazole—Nervous system disorder—Docetaxel—head and neck cancer	0.000511	0.0011	CcSEcCtD
Voriconazole—Pruritus—Fluorouracil—head and neck cancer	0.00051	0.0011	CcSEcCtD
Voriconazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.00051	0.0011	CcSEcCtD
Voriconazole—Tachycardia—Docetaxel—head and neck cancer	0.000508	0.00109	CcSEcCtD
Voriconazole—Skin disorder—Docetaxel—head and neck cancer	0.000506	0.00109	CcSEcCtD
Voriconazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000504	0.00718	CbGpPWpGaD
Voriconazole—Anorexia—Docetaxel—head and neck cancer	0.000496	0.00107	CcSEcCtD
Voriconazole—Diarrhoea—Fluorouracil—head and neck cancer	0.000494	0.00106	CcSEcCtD
Voriconazole—FMO3—Metabolism—UROD—head and neck cancer	0.000487	0.00695	CbGpPWpGaD
Voriconazole—Hypotension—Docetaxel—head and neck cancer	0.000486	0.00105	CcSEcCtD
Voriconazole—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000484	0.00689	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—NAT2—head and neck cancer	0.000479	0.00683	CbGpPWpGaD
Voriconazole—Dizziness—Fluorouracil—head and neck cancer	0.000477	0.00103	CcSEcCtD
Voriconazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000474	0.00102	CcSEcCtD
Voriconazole—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.000472	0.00673	CbGpPWpGaD
Voriconazole—Insomnia—Docetaxel—head and neck cancer	0.000471	0.00101	CcSEcCtD
Voriconazole—Paraesthesia—Docetaxel—head and neck cancer	0.000467	0.00101	CcSEcCtD
Voriconazole—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000464	0.00662	CbGpPWpGaD
Voriconazole—Dyspnoea—Docetaxel—head and neck cancer	0.000464	0.001	CcSEcCtD
Voriconazole—Somnolence—Docetaxel—head and neck cancer	0.000463	0.000997	CcSEcCtD
Voriconazole—Vomiting—Fluorouracil—head and neck cancer	0.000459	0.000988	CcSEcCtD
Voriconazole—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000458	0.00653	CbGpPWpGaD
Voriconazole—Dyspepsia—Docetaxel—head and neck cancer	0.000458	0.000987	CcSEcCtD
Voriconazole—Rash—Fluorouracil—head and neck cancer	0.000455	0.000979	CcSEcCtD
Voriconazole—Dermatitis—Fluorouracil—head and neck cancer	0.000454	0.000979	CcSEcCtD
Voriconazole—Decreased appetite—Docetaxel—head and neck cancer	0.000453	0.000975	CcSEcCtD
Voriconazole—Headache—Fluorouracil—head and neck cancer	0.000452	0.000973	CcSEcCtD
Voriconazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000449	0.000968	CcSEcCtD
Voriconazole—Pain—Docetaxel—head and neck cancer	0.000445	0.000959	CcSEcCtD
Voriconazole—Constipation—Docetaxel—head and neck cancer	0.000445	0.000959	CcSEcCtD
Voriconazole—Feeling abnormal—Docetaxel—head and neck cancer	0.000429	0.000924	CcSEcCtD
Voriconazole—Nausea—Fluorouracil—head and neck cancer	0.000428	0.000923	CcSEcCtD
Voriconazole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000426	0.000917	CcSEcCtD
Voriconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000422	0.00602	CbGpPWpGaD
Voriconazole—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000421	0.00601	CbGpPWpGaD
Voriconazole—Abdominal pain—Docetaxel—head and neck cancer	0.000412	0.000886	CcSEcCtD
Voriconazole—Body temperature increased—Docetaxel—head and neck cancer	0.000412	0.000886	CcSEcCtD
Voriconazole—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000409	0.00583	CbGpPWpGaD
Voriconazole—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000405	0.00578	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000393	0.00561	CbGpPWpGaD
Voriconazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000385	0.00549	CbGpPWpGaD
Voriconazole—Hypersensitivity—Docetaxel—head and neck cancer	0.000384	0.000826	CcSEcCtD
Voriconazole—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00038	0.00542	CbGpPWpGaD
Voriconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000376	0.00537	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000375	0.00535	CbGpPWpGaD
Voriconazole—Asthenia—Docetaxel—head and neck cancer	0.000374	0.000804	CcSEcCtD
Voriconazole—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000371	0.00529	CbGpPWpGaD
Voriconazole—Pruritus—Docetaxel—head and neck cancer	0.000368	0.000793	CcSEcCtD
Voriconazole—Diarrhoea—Docetaxel—head and neck cancer	0.000356	0.000767	CcSEcCtD
Voriconazole—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000354	0.00505	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000349	0.00498	CbGpPWpGaD
Voriconazole—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000347	0.00495	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000346	0.00493	CbGpPWpGaD
Voriconazole—Dizziness—Docetaxel—head and neck cancer	0.000344	0.000741	CcSEcCtD
Voriconazole—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000341	0.00487	CbGpPWpGaD
Voriconazole—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00034	0.00485	CbGpPWpGaD
Voriconazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000337	0.0048	CbGpPWpGaD
Voriconazole—Vomiting—Docetaxel—head and neck cancer	0.000331	0.000713	CcSEcCtD
Voriconazole—Rash—Docetaxel—head and neck cancer	0.000328	0.000707	CcSEcCtD
Voriconazole—Dermatitis—Docetaxel—head and neck cancer	0.000328	0.000706	CcSEcCtD
Voriconazole—Headache—Docetaxel—head and neck cancer	0.000326	0.000702	CcSEcCtD
Voriconazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000312	0.00445	CbGpPWpGaD
Voriconazole—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00031	0.00442	CbGpPWpGaD
Voriconazole—Nausea—Docetaxel—head and neck cancer	0.000309	0.000666	CcSEcCtD
Voriconazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000307	0.00438	CbGpPWpGaD
Voriconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000305	0.00435	CbGpPWpGaD
Voriconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000291	0.00415	CbGpPWpGaD
Voriconazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000287	0.00409	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—NAT2—head and neck cancer	0.000283	0.00403	CbGpPWpGaD
Voriconazole—FMO3—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000281	0.004	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000268	0.00381	CbGpPWpGaD
Voriconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000265	0.00378	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000264	0.00376	CbGpPWpGaD
Voriconazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000262	0.00373	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—DPYD—head and neck cancer	0.000248	0.00354	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000244	0.00348	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000241	0.00343	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000237	0.00337	CbGpPWpGaD
Voriconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000236	0.00336	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—YAP1—head and neck cancer	0.000235	0.00336	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000233	0.00333	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000229	0.00327	CbGpPWpGaD
Voriconazole—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000224	0.0032	CbGpPWpGaD
Voriconazole—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000221	0.00315	CbGpPWpGaD
Voriconazole—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000221	0.00315	CbGpPWpGaD
Voriconazole—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000217	0.0031	CbGpPWpGaD
Voriconazole—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000216	0.00308	CbGpPWpGaD
Voriconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000215	0.00307	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—NAT2—head and neck cancer	0.000202	0.00288	CbGpPWpGaD
Voriconazole—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.0002	0.00285	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—UROD—head and neck cancer	0.000197	0.00281	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—UROD—head and neck cancer	0.000191	0.00272	CbGpPWpGaD
Voriconazole—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000183	0.0026	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—DPYD—head and neck cancer	0.000177	0.00253	CbGpPWpGaD
Voriconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000175	0.00249	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000175	0.00249	CbGpPWpGaD
Voriconazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000173	0.00246	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000173	0.00246	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000171	0.00244	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000169	0.0024	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—YAP1—head and neck cancer	0.000168	0.0024	CbGpPWpGaD
Voriconazole—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000166	0.00236	CbGpPWpGaD
Voriconazole—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000164	0.00233	CbGpPWpGaD
Voriconazole—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000162	0.00231	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000161	0.00229	CbGpPWpGaD
Voriconazole—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00016	0.00228	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000159	0.00226	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000148	0.00211	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—UROD—head and neck cancer	0.000146	0.00208	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—UROD—head and neck cancer	0.000143	0.00203	CbGpPWpGaD
Voriconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000142	0.00202	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—TYMS—head and neck cancer	0.000141	0.00202	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—GSTM1—head and neck cancer	0.00014	0.00199	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—GPX1—head and neck cancer	0.000134	0.00191	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—CYP1A1—head and neck cancer	0.000133	0.00189	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000132	0.00188	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.00013	0.00186	CbGpPWpGaD
Voriconazole—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000125	0.00179	CbGpPWpGaD
Voriconazole—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000124	0.00176	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000121	0.00172	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000119	0.00169	CbGpPWpGaD
Voriconazole—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000114	0.00163	CbGpPWpGaD
Voriconazole—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000113	0.00161	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—UROD—head and neck cancer	0.00011	0.00157	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—TYMS—head and neck cancer	0.000101	0.00144	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—UROD—head and neck cancer	0.0001	0.00143	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GSTM1—head and neck cancer	9.99e-05	0.00142	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—GPX1—head and neck cancer	9.57e-05	0.00136	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—CYP1A1—head and neck cancer	9.47e-05	0.00135	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.55e-05	0.00122	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.43e-05	0.0012	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.35e-05	0.00119	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—NAT2—head and neck cancer	8.19e-05	0.00117	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.95e-05	0.00113	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—NAT2—head and neck cancer	7.94e-05	0.00113	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTGS2—head and neck cancer	7.88e-05	0.00112	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.84e-05	0.00112	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.8e-05	0.00111	CbGpPWpGaD
Voriconazole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	7.53e-05	0.00107	CbGpPWpGaD
Voriconazole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	7.43e-05	0.00106	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—DPYD—head and neck cancer	7.18e-05	0.00102	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—DPYD—head and neck cancer	6.96e-05	0.000992	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PTEN—head and neck cancer	6.87e-05	0.00098	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—YAP1—head and neck cancer	6.81e-05	0.000971	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—UROD—head and neck cancer	6.63e-05	0.000945	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—YAP1—head and neck cancer	6.61e-05	0.000942	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—NAT2—head and neck cancer	6.06e-05	0.000863	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—NAT2—head and neck cancer	5.92e-05	0.000844	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTGS2—head and neck cancer	5.63e-05	0.000803	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—DPYD—head and neck cancer	5.31e-05	0.000757	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—DPYD—head and neck cancer	5.19e-05	0.00074	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—YAP1—head and neck cancer	5.04e-05	0.000718	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.96e-05	0.000707	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—YAP1—head and neck cancer	4.93e-05	0.000702	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PTEN—head and neck cancer	4.91e-05	0.0007	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.86e-05	0.000693	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—PIK3CA—head and neck cancer	4.85e-05	0.000691	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.81e-05	0.000686	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—NAT2—head and neck cancer	4.58e-05	0.000652	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.43e-05	0.000632	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.39e-05	0.000625	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.33e-05	0.000617	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—NAT2—head and neck cancer	4.17e-05	0.000595	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—TYMS—head and neck cancer	4.09e-05	0.000583	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GSTM1—head and neck cancer	4.04e-05	0.000577	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—DPYD—head and neck cancer	4.01e-05	0.000572	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—TYMS—head and neck cancer	3.97e-05	0.000565	CbGpPWpGaD
Voriconazole—FMO1—Metabolism—AKT1—head and neck cancer	3.96e-05	0.000565	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GSTM1—head and neck cancer	3.92e-05	0.000559	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—GPX1—head and neck cancer	3.87e-05	0.000552	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—CYP1A1—head and neck cancer	3.83e-05	0.000547	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—YAP1—head and neck cancer	3.81e-05	0.000543	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—GPX1—head and neck cancer	3.75e-05	0.000535	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.72e-05	0.00053	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—DPYD—head and neck cancer	3.66e-05	0.000522	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—YAP1—head and neck cancer	3.47e-05	0.000495	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—PIK3CA—head and neck cancer	3.47e-05	0.000494	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.05e-05	0.000435	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—TYMS—head and neck cancer	3.03e-05	0.000431	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GSTM1—head and neck cancer	2.99e-05	0.000426	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—TYMS—head and neck cancer	2.96e-05	0.000422	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.92e-05	0.000417	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—GPX1—head and neck cancer	2.86e-05	0.000408	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.86e-05	0.000408	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—CYP1A1—head and neck cancer	2.84e-05	0.000404	CbGpPWpGaD
Voriconazole—FMO3—Metabolism—AKT1—head and neck cancer	2.83e-05	0.000404	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—GPX1—head and neck cancer	2.8e-05	0.000399	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.77e-05	0.000395	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—NAT2—head and neck cancer	2.75e-05	0.000392	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.61e-05	0.000372	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.5e-05	0.000356	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—DPYD—head and neck cancer	2.41e-05	0.000344	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—YAP1—head and neck cancer	2.29e-05	0.000326	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—TYMS—head and neck cancer	2.29e-05	0.000326	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTGS2—head and neck cancer	2.28e-05	0.000325	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.28e-05	0.000324	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.26e-05	0.000322	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTGS2—head and neck cancer	2.21e-05	0.000315	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—GPX1—head and neck cancer	2.16e-05	0.000309	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.14e-05	0.000305	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—TYMS—head and neck cancer	2.09e-05	0.000297	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.06e-05	0.000294	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PTEN—head and neck cancer	1.99e-05	0.000283	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—GPX1—head and neck cancer	1.97e-05	0.000281	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.95e-05	0.000279	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PTEN—head and neck cancer	1.93e-05	0.000275	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.76e-05	0.000251	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.69e-05	0.00024	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.65e-05	0.000235	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.61e-05	0.000229	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PTEN—head and neck cancer	1.47e-05	0.00021	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PTEN—head and neck cancer	1.44e-05	0.000205	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.4e-05	0.0002	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—TYMS—head and neck cancer	1.38e-05	0.000196	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.36e-05	0.000194	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.36e-05	0.000194	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—GPX1—head and neck cancer	1.3e-05	0.000186	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.29e-05	0.000184	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.27e-05	0.000182	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.16e-05	0.000166	CbGpPWpGaD
Voriconazole—CYP3A7—Metabolism—AKT1—head and neck cancer	1.15e-05	0.000163	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PTEN—head and neck cancer	1.11e-05	0.000158	CbGpPWpGaD
Voriconazole—PTGS1—Metabolism—AKT1—head and neck cancer	1.11e-05	0.000158	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.04e-05	0.000148	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.01e-05	0.000145	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PTEN—head and neck cancer	1.01e-05	0.000144	CbGpPWpGaD
Voriconazole—CYP2B6—Metabolism—AKT1—head and neck cancer	8.48e-06	0.000121	CbGpPWpGaD
Voriconazole—CYP3A5—Metabolism—AKT1—head and neck cancer	8.28e-06	0.000118	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—PIK3CA—head and neck cancer	7.84e-06	0.000112	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.66e-06	0.000109	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.15e-06	0.000102	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PTEN—head and neck cancer	6.68e-06	9.53e-05	CbGpPWpGaD
Voriconazole—CYP2C19—Metabolism—AKT1—head and neck cancer	6.4e-06	9.13e-05	CbGpPWpGaD
Voriconazole—CYP2C9—Metabolism—AKT1—head and neck cancer	5.84e-06	8.32e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.71e-06	6.72e-05	CbGpPWpGaD
Voriconazole—CYP3A4—Metabolism—AKT1—head and neck cancer	3.85e-06	5.49e-05	CbGpPWpGaD
